IMS, Quintiles Names Leadership to Merged CompanyBy
IMS Health Holdings and Quintiles Transnational Holdings have announced key senior management roles in the future Quintiles IMS corporate leadership team, subject to the completion of their merger, which is expected to close in the second half of 2016. The companies announced their agreement to merge in a deal valued at $8.75 billion in May 2016.
Senior functional leaders reporting to chairman and chief executive officer, Ari Bousbib, will include Michael McDonnell, executive vice president (EVP) and chief financial officer; James Erlinger, EVP and general counsel; and Trudy Stein, EVP and chief human resources officer.
Global business leaders reporting to Mr. Bousbib will include, for the clinical research business, Tom Pike, vice chairman and president, research and development solutions; and for the commercial business, Kevin Knightly, president, information and technology solutions; JosÃ© Luis FernÃ¡ndez, president, global services; Jon Resnick, president, real-world insights; and Scott Evangelista, president, contract sales organization.
Source: IMS Health Holdings